Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine
H Chaytow, KME Faller, YT Huang… - Cell Reports Medicine, 2021 - cell.com
Spinal muscular atrophy (SMA) is a devastating childhood motor neuron disease that, in the
most severe cases and when left untreated, leads to death within the first two years of life …
most severe cases and when left untreated, leads to death within the first two years of life …
The role of survival motor neuron protein (SMN) in protein homeostasis
H Chaytow, YT Huang, TH Gillingwater… - Cellular and Molecular …, 2018 - Springer
Ever since loss of survival motor neuron (SMN) protein was identified as the direct cause of
the childhood inherited neurodegenerative disorder spinal muscular atrophy, significant …
the childhood inherited neurodegenerative disorder spinal muscular atrophy, significant …
Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases
O Corti, K Blomgren, A Poletti… - Journal of …, 2020 - Wiley Online Library
In autophagy long‐lived proteins, protein aggregates or damaged organelles are engulfed
by vesicles called autophagosomes prior to lysosomal degradation. Autophagy dysfunction …
by vesicles called autophagosomes prior to lysosomal degradation. Autophagy dysfunction …
[HTML][HTML] Autophagy in sarcopenia: Possible mechanisms and novel therapies
G Xie, H Jin, H Mikhail, V Pavel, G Yang, B Ji… - Biomedicine & …, 2023 - Elsevier
With global population aging, age-related diseases, especially sarcopenia, have attracted
much attention in recent years. Characterized by low muscle strength, low muscle quantity or …
much attention in recent years. Characterized by low muscle strength, low muscle quantity or …
Isoquercitrin delays denervated soleus muscle atrophy by inhibiting oxidative stress and inflammation
Y Shen, Q Zhang, Z Huang, J Zhu, J Qiu, W Ma… - Frontiers in …, 2020 - frontiersin.org
Although denervated muscle atrophy is common, the underlying molecular mechanism
remains unelucidated. We have previously found that oxidative stress and inflammatory …
remains unelucidated. We have previously found that oxidative stress and inflammatory …
Mitochondrial dysfunction in spinal muscular atrophy
Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder caused by
recessive mutations in the SMN1 gene, globally affecting~ 8–14 newborns per 100,000. The …
recessive mutations in the SMN1 gene, globally affecting~ 8–14 newborns per 100,000. The …
Drug screening and drug repositioning as promising therapeutic approaches for spinal muscular atrophy treatment
Spinal muscular atrophy (SMA) is the most common genetic disease affecting infants and
young adults. Due to mutation/deletion of the survival motor neuron (SMN) gene, SMA is …
young adults. Due to mutation/deletion of the survival motor neuron (SMN) gene, SMA is …
Stasimon contributes to the loss of sensory synapses and motor neuron death in a mouse model of spinal muscular atrophy
Reduced expression of the survival motor neuron (SMN) protein causes the
neurodegenerative disease spinal muscular atrophy (SMA). Here, we show that adeno …
neurodegenerative disease spinal muscular atrophy (SMA). Here, we show that adeno …
Revisiting the role of mitochondria in spinal muscular atrophy
Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease of variable
clinical severity that is caused by mutations in the survival motor neuron 1 (SMN1) gene …
clinical severity that is caused by mutations in the survival motor neuron 1 (SMN1) gene …
Lipid microcapsules promoted neural stem cell survival in the infarcted area of mice with ischemic stroke by inducing autophagy
R Xu, C Duan, Z Meng, J Zhao, Q He… - ACS Biomaterials …, 2022 - ACS Publications
Intracerebral transplantation of neural stem cells (NSCs) for ischemic stroke treatment has
been demonstrated to be inefficient, with only< 5% of delivered cells being retained …
been demonstrated to be inefficient, with only< 5% of delivered cells being retained …